Copyright Reports & Markets. All rights reserved.

Global Orthopedic Hyaluronic Acid Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Orthopedic Hyaluronic Acid Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Orthopedic Hyaluronic Acid Market Size Growth Rate by Product
      • 1.4.2 Single Injection
      • 1.4.3 Three Injection
      • 1.4.4 Five Injection
    • 1.5 Market by End User
      • 1.5.1 Global Orthopedic Hyaluronic Acid Market Size Growth Rate by End User
      • 1.5.2 Hospitals
      • 1.5.3 Ambulatory Surgical Centres
      • 1.5.4 Orthopaedic Clinics
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Orthopedic Hyaluronic Acid Market Size
      • 2.1.1 Global Orthopedic Hyaluronic Acid Revenue 2014-2025
      • 2.1.2 Global Orthopedic Hyaluronic Acid Sales 2014-2025
    • 2.2 Orthopedic Hyaluronic Acid Growth Rate by Regions
      • 2.2.1 Global Orthopedic Hyaluronic Acid Sales by Regions
      • 2.2.2 Global Orthopedic Hyaluronic Acid Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Orthopedic Hyaluronic Acid Sales by Manufacturers
      • 3.1.1 Orthopedic Hyaluronic Acid Sales by Manufacturers
      • 3.1.2 Orthopedic Hyaluronic Acid Sales Market Share by Manufacturers
      • 3.1.3 Global Orthopedic Hyaluronic Acid Market Concentration Ratio (CR5 and HHI)
    • 3.2 Orthopedic Hyaluronic Acid Revenue by Manufacturers
      • 3.2.1 Orthopedic Hyaluronic Acid Revenue by Manufacturers (2014-2019)
      • 3.2.2 Orthopedic Hyaluronic Acid Revenue Share by Manufacturers (2014-2019)
    • 3.3 Orthopedic Hyaluronic Acid Price by Manufacturers
    • 3.4 Orthopedic Hyaluronic Acid Manufacturing Base Distribution, Product Types
      • 3.4.1 Orthopedic Hyaluronic Acid Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Orthopedic Hyaluronic Acid Product Type
      • 3.4.3 Date of International Manufacturers Enter into Orthopedic Hyaluronic Acid Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Orthopedic Hyaluronic Acid Sales by Product
    • 4.2 Global Orthopedic Hyaluronic Acid Revenue by Product
    • 4.3 Orthopedic Hyaluronic Acid Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Orthopedic Hyaluronic Acid Breakdown Data by End User

    6 North America

    • 6.1 North America Orthopedic Hyaluronic Acid by Countries
      • 6.1.1 North America Orthopedic Hyaluronic Acid Sales by Countries
      • 6.1.2 North America Orthopedic Hyaluronic Acid Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Orthopedic Hyaluronic Acid by Product
    • 6.3 North America Orthopedic Hyaluronic Acid by End User

    7 Europe

    • 7.1 Europe Orthopedic Hyaluronic Acid by Countries
      • 7.1.1 Europe Orthopedic Hyaluronic Acid Sales by Countries
      • 7.1.2 Europe Orthopedic Hyaluronic Acid Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Orthopedic Hyaluronic Acid by Product
    • 7.3 Europe Orthopedic Hyaluronic Acid by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Orthopedic Hyaluronic Acid by Countries
      • 8.1.1 Asia Pacific Orthopedic Hyaluronic Acid Sales by Countries
      • 8.1.2 Asia Pacific Orthopedic Hyaluronic Acid Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Orthopedic Hyaluronic Acid by Product
    • 8.3 Asia Pacific Orthopedic Hyaluronic Acid by End User

    9 Central & South America

    • 9.1 Central & South America Orthopedic Hyaluronic Acid by Countries
      • 9.1.1 Central & South America Orthopedic Hyaluronic Acid Sales by Countries
      • 9.1.2 Central & South America Orthopedic Hyaluronic Acid Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Orthopedic Hyaluronic Acid by Product
    • 9.3 Central & South America Orthopedic Hyaluronic Acid by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Orthopedic Hyaluronic Acid by Countries
      • 10.1.1 Middle East and Africa Orthopedic Hyaluronic Acid Sales by Countries
      • 10.1.2 Middle East and Africa Orthopedic Hyaluronic Acid Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Orthopedic Hyaluronic Acid by Product
    • 10.3 Middle East and Africa Orthopedic Hyaluronic Acid by End User

    11 Company Profiles

    • 11.1 Anika Therapeutics
      • 11.1.1 Anika Therapeutics Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Anika Therapeutics Orthopedic Hyaluronic Acid Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Anika Therapeutics Orthopedic Hyaluronic Acid Products Offered
      • 11.1.5 Anika Therapeutics Recent Development
    • 11.2 Seikagaku Corporation
      • 11.2.1 Seikagaku Corporation Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Seikagaku Corporation Orthopedic Hyaluronic Acid Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Seikagaku Corporation Orthopedic Hyaluronic Acid Products Offered
      • 11.2.5 Seikagaku Corporation Recent Development
    • 11.3 Galderma
      • 11.3.1 Galderma Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Galderma Orthopedic Hyaluronic Acid Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Galderma Orthopedic Hyaluronic Acid Products Offered
      • 11.3.5 Galderma Recent Development
    • 11.4 Sanofi (Genzyme)
      • 11.4.1 Sanofi (Genzyme) Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Sanofi (Genzyme) Orthopedic Hyaluronic Acid Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Sanofi (Genzyme) Orthopedic Hyaluronic Acid Products Offered
      • 11.4.5 Sanofi (Genzyme) Recent Development
    • 11.5 Salix Pharmaceuticals
      • 11.5.1 Salix Pharmaceuticals Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Salix Pharmaceuticals Orthopedic Hyaluronic Acid Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Salix Pharmaceuticals Orthopedic Hyaluronic Acid Products Offered
      • 11.5.5 Salix Pharmaceuticals Recent Development
    • 11.6 Allergan
      • 11.6.1 Allergan Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Allergan Orthopedic Hyaluronic Acid Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Allergan Orthopedic Hyaluronic Acid Products Offered
      • 11.6.5 Allergan Recent Development
    • 11.7 Roche
      • 11.7.1 Roche Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Roche Orthopedic Hyaluronic Acid Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Roche Orthopedic Hyaluronic Acid Products Offered
      • 11.7.5 Roche Recent Development
    • 11.8 Zimmer
      • 11.8.1 Zimmer Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Zimmer Orthopedic Hyaluronic Acid Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Zimmer Orthopedic Hyaluronic Acid Products Offered
      • 11.8.5 Zimmer Recent Development
    • 11.9 Ferring Pharmaceuticals
      • 11.9.1 Ferring Pharmaceuticals Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Ferring Pharmaceuticals Orthopedic Hyaluronic Acid Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Ferring Pharmaceuticals Orthopedic Hyaluronic Acid Products Offered
      • 11.9.5 Ferring Pharmaceuticals Recent Development
    • 11.10 Smith & Nephew
      • 11.10.1 Smith & Nephew Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Smith & Nephew Orthopedic Hyaluronic Acid Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Smith & Nephew Orthopedic Hyaluronic Acid Products Offered
      • 11.10.5 Smith & Nephew Recent Development

    12 Future Forecast

    • 12.1 Orthopedic Hyaluronic Acid Market Forecast by Regions
      • 12.1.1 Global Orthopedic Hyaluronic Acid Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Orthopedic Hyaluronic Acid Revenue Forecast by Regions 2019-2025
    • 12.2 Orthopedic Hyaluronic Acid Market Forecast by Product
      • 12.2.1 Global Orthopedic Hyaluronic Acid Sales Forecast by Product 2019-2025
      • 12.2.2 Global Orthopedic Hyaluronic Acid Revenue Forecast by Product 2019-2025
    • 12.3 Orthopedic Hyaluronic Acid Market Forecast by End User
    • 12.4 North America Orthopedic Hyaluronic Acid Forecast
    • 12.5 Europe Orthopedic Hyaluronic Acid Forecast
    • 12.6 Asia Pacific Orthopedic Hyaluronic Acid Forecast
    • 12.7 Central & South America Orthopedic Hyaluronic Acid Forecast
    • 12.8 Middle East and Africa Orthopedic Hyaluronic Acid Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Orthopedic Hyaluronic Acid Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      hyaluronic acid is a glycosaminoglycan found in synovial fluid & cartilage
      The global Orthopedic Hyaluronic Acid market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Orthopedic Hyaluronic Acid market based on company, product type, end user and key regions.

      This report studies the global market size of Orthopedic Hyaluronic Acid in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Orthopedic Hyaluronic Acid in these regions.
      This research report categorizes the global Orthopedic Hyaluronic Acid market by top players/brands, region, type and end user. This report also studies the global Orthopedic Hyaluronic Acid market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Anika Therapeutics
      Seikagaku Corporation
      Galderma
      Sanofi (Genzyme)
      Salix Pharmaceuticals
      Allergan
      Roche
      Zimmer
      Ferring Pharmaceuticals
      Smith & Nephew

      Market size by Product
      Single Injection
      Three Injection
      Five Injection
      Market size by End User
      Hospitals
      Ambulatory Surgical Centres
      Orthopaedic Clinics

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Orthopedic Hyaluronic Acid market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Orthopedic Hyaluronic Acid market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Orthopedic Hyaluronic Acid companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Orthopedic Hyaluronic Acid submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Orthopedic Hyaluronic Acid are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Orthopedic Hyaluronic Acid market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now